Building The Worm Atlas For I&I Breakthroughs

The next big thing in auto-immune therapies: worms. Or so a young California biotech believes. Holoclara is pioneering a new class of medicines derived from intestinal worms to revolutionize the treatment of autoimmune diseases, allergies, and more.

Andrea Choe, CEO at Holoclara

More from New Science

More from Leadership